Note: Ingredients listed on restricted chemical lists
EC/CAS
200-663-8/67-66-3
Name of the chemical
Chloroform
Concentration
>=1-<3%
General Information
Version
6.11
Revision date
2023-12-30
Product name
Conductivity Standard
REACH No
This
Emergency telephone
+49 (0)696 43508409
Icons in SDS
Company Information
company name
Sigma-Aldrich Chemie GmbH
e-mail address of the competent person responsible for the Safety Data Sheet
technischerservice@merckgroup.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H351, H373
Hazard statements
Code
Statements
H351
Suspected of causing cancer
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Carcinogenicity, (Category 2) H351: Suspected of causing cancer. Specific target organ toxicity - H373: May cause damage to organs repeated exposure, (Category 2) through prolonged or repeated exposure.
2.2 Label elements
Labelling
Signal word
Warning Warning
Hazard statements
H351 Suspected of causing cancer. H373 May cause damage to organs through prolonged or repeated exposure. For use in industrial installations only. Reduced Labeling (<= 125 ml) H351 Suspected of causing cancer.
Precautionary statements
P201 Obtain special instructions before use. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P201 Obtain special instructions before use. P308 + P313 IF exposed or concerned: Get medical advice/ attention.
Supplemental label elements
none none
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
